These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 33782808)
41. Age-Related Decrease in Skeletal Muscle Mass Is an Independent Risk Factor for Incident Nonalcoholic Fatty Liver Disease: A 10-Year Retrospective Cohort Study. Lee MJ; Kim EH; Bae SJ; Kim GA; Park SW; Choe J; Jung CH; Lee WJ; Kim HK Gut Liver; 2019 Jan; 13(1):67-76. PubMed ID: 30037166 [TBL] [Abstract][Full Text] [Related]
42. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340 [TBL] [Abstract][Full Text] [Related]
43. Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity-matched cohort study. Park H; Dawwas GK; Liu X; Nguyen MH J Intern Med; 2019 Dec; 286(6):711-722. PubMed ID: 31359543 [TBL] [Abstract][Full Text] [Related]
44. Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension. Sung KC; Wild SH; Byrne CD J Hepatol; 2014 May; 60(5):1040-5. PubMed ID: 24445219 [TBL] [Abstract][Full Text] [Related]
45. Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease. Church TS; Kuk JL; Ross R; Priest EL; Biltoft E; Blair SN Gastroenterology; 2006 Jun; 130(7):2023-30. PubMed ID: 16762625 [TBL] [Abstract][Full Text] [Related]
46. Systemic Complications of Nonalcoholic Fatty Liver Disease: When the Liver Is Not an Innocent Bystander. Vanni E; Marengo A; Mezzabotta L; Bugianesi E Semin Liver Dis; 2015 Aug; 35(3):236-49. PubMed ID: 26378641 [TBL] [Abstract][Full Text] [Related]
47. Cardiovascular Disease, Cancer, and Mortality Among People With Type 2 Diabetes and Alcoholic or Nonalcoholic Fatty Liver Disease Hospital Admission. Wild SH; Walker JJ; Morling JR; McAllister DA; Colhoun HM; Farran B; McGurnaghan S; McCrimmon R; Read SH; Sattar N; Byrne CD; Diabetes Care; 2018 Feb; 41(2):341-347. PubMed ID: 29167212 [TBL] [Abstract][Full Text] [Related]
48. Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease. Arvind A; Henson JB; Osganian SA; Nath C; Steinhagen LM; Memel ZN; Donovan A; Balogun O; Chung RT; Simon TG; Corey KE Hepatol Commun; 2022 Feb; 6(2):309-319. PubMed ID: 34558862 [TBL] [Abstract][Full Text] [Related]
49. Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes. Käräjämäki AJ; Bloigu R; Kauma H; Kesäniemi YA; Koivurova OP; Perkiömäki J; Huikuri H; Ukkola O Metabolism; 2017 Jan; 66():55-63. PubMed ID: 27423871 [TBL] [Abstract][Full Text] [Related]
50. Relative fat mass at baseline and its early change may be a predictor of incident nonalcoholic fatty liver disease. Kim HY; Baik SJ; Lee HA; Lee BK; Lee HS; Kim TH; Yoo K Sci Rep; 2020 Oct; 10(1):17491. PubMed ID: 33060775 [TBL] [Abstract][Full Text] [Related]
51. Nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and its association with cardiovascular disease. Vanjiappan S; Hamide A; Ananthakrishnan R; Periyasamy SG; Mehalingam V Diabetes Metab Syndr; 2018 Jul; 12(4):479-482. PubMed ID: 29402657 [TBL] [Abstract][Full Text] [Related]
52. Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study. Tuttolomondo A; Petta S; Casuccio A; Maida C; Corte VD; Daidone M; Di Raimondo D; Pecoraro R; Fonte R; Cirrincione A; Zafonte R; Cabibi D; Cammà C; Di Marco V; Licata A; Magliozzo F; Marchesini G; Merlino G; Craxì A; Pinto A Cardiovasc Diabetol; 2018 Feb; 17(1):28. PubMed ID: 29452601 [TBL] [Abstract][Full Text] [Related]
53. Ideal Cardiovascular Health Is Inversely Associated with Nonalcoholic Fatty Liver Disease: A Prospective Analysis. Wang L; Li M; Zhao Z; Xu M; Lu J; Wang T; Chen Y; Wang S; Dai M; Hou Y; Wu X; Ma L; Li L; Liu S; Wang W; Xu Y; Bi Y; Ning G Am J Med; 2018 Dec; 131(12):1515.e1-1515.e10. PubMed ID: 30075104 [TBL] [Abstract][Full Text] [Related]
54. The association of hepatic steatosis and fibrosis with heart failure and mortality. Park J; Kim G; Kim H; Lee J; Lee YB; Jin SM; Hur KY; Kim JH Cardiovasc Diabetol; 2021 Sep; 20(1):197. PubMed ID: 34583706 [TBL] [Abstract][Full Text] [Related]
55. Cardiovascular Risk in Children with Nonalcoholic Fatty Liver Disease (NAFLD). Chociej AB; Wasilewska N; Flisiak-Jackiewicz M; Lebensztejn D Curr Pediatr Rev; 2020; 16(4):294-297. PubMed ID: 33038914 [TBL] [Abstract][Full Text] [Related]
56. Increased risk of non-alcoholic fatty liver disease in women with gestational diabetes mellitus: A population-based cohort study, systematic review and meta-analysis. Lavrentaki A; Thomas T; Subramanian A; Valsamakis G; Thomas N; Toulis KA; Wang J; Daly B; Saravanan P; Sumilo D; Mastorakos G; Tahrani AA; Nirantharakumar K J Diabetes Complications; 2019 Oct; 33(10):107401. PubMed ID: 31326267 [TBL] [Abstract][Full Text] [Related]